Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Oncternal Therapeutics Inc ONCT

Healthcare Biotechnology
Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of oncology therapies for the treatment of patients with cancers that have critical unmet medical needs. The Company’s product candidates include ONCT-534, ONCT-808, Zilovertamab, and ONCT-216. ONCT-534 is a dual-action androgen receptor inhibitor (DAARI), for the treatment of... see more

Recent & Breaking News (NDAQ:ONCT)

Lifshitz & Miller LLP Announces Investigation of Amarin Corporation plc, Clementia Pharmaceuticals Inc., CVS Health Corporation, Diplomat Pharmacy, Inc., GTx, Inc., Multi-Color Corporation, Osiris Therapeutics, Inc., and The Kraft Heinz Company

PR Newswire March 22, 2019

Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Civitas, Entegra, and Immune Design on Behalf of Stockholders and Encourages Investors to Contact the Firm

GlobeNewswire March 20, 2019

GTX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of GTx, Inc. - GTXI

PR Newswire March 11, 2019

GTX, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Merger

Business Wire March 7, 2019

Mid-Afternoon Market Update: Resideo Technologies Drops After Q4 Earnings; Seelos Therapeutics Shares Climb

Benzinga.com  March 7, 2019

Mid-Day Market Update: Titan International Falls Following Downbeat Q4 Results; GTx Shares Jump

Benzinga.com  March 7, 2019

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of GTx, Inc. to Oncternal Therapeutics, Inc. is Fair to Shareholders

GlobeNewswire March 7, 2019

Mid-Morning Market Update: Markets Open Lower; Kroger Misses Q4 Expectations

Benzinga.com  March 7, 2019

GTx and Oncternal Therapeutics Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage Company Developing a Diverse Pipeline of Novel Cancer Therapies

Business Wire March 7, 2019

Recent Analysis Shows Automatic Data Processing, GTx, Ionis Pharmaceuticals, TriNet Group, Ternium S.A, and UNIVERSAL INSURANCE HOLDINGS INC Market Influences — Renewed Outlook, Key Drivers of Growth

GlobeNewswire November 8, 2018

GTx Reports Third Quarter 2018 Financial Results and Provides Corporate Update

Business Wire October 22, 2018

New Research Coverage Highlights Adesto Technologies, Pain Therapeutics, U.S. Global Investors, GTx, Columbus McKinnon, and Baytex Energy — Consolidated Revenues, Company Growth, and Expectations for 2018

GlobeNewswire October 16, 2018

Mid-Afternoon Market Update: SMART Global Jumps Following Strong Q4 Results; Aytu BioScience Shares Slide

Benzinga.com  October 5, 2018

36 Stocks Moving In Friday's Mid-Day Session

Benzinga.com  October 5, 2018

23 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  October 5, 2018

The Daily Biotech Pulse: AtriCure's Guidance, Guardant Health And Kodiak To Debut

Benzinga.com  October 4, 2018

The Daily Biotech Pulse: Endologix's Q3 Sales, Obseva's Positive Trial Results, Kala To Offer Shares

Benzinga.com  October 3, 2018

52 Biggest Movers From Friday

Benzinga.com  September 24, 2018

Mid-Afternoon Market Update: Steelcase Surges On Earnings Beat; GTx Shares Slide

Benzinga.com  September 21, 2018

Mid-Day Market Update: Mazor Robotics Climbs Following Acquisition News; GTx Shares Plunge

Benzinga.com  September 21, 2018